In vitro activity of ofloxacin and ciprofloxacin against Mycobacterium tuberculosis strains
Aysev, A.D.
Mikrobiyoloji Bulteni 27(1): 31-35
1993
ISSN/ISBN: 0374-9096 PMID: 8421440 Document Number: 417266
The activity of Ofloxacin and Ciprofloxacin against 50 strains of M. tuberculosis were investigated in-vitro on Löwenstein-Jensen medium. Minimal Inhibitory Concentration (MIC90) of Ofloxacin and Ciprofloxacin were found 1 mg/L and 4 mg/L, respectively. There were no difference in susceptibility to Ofloxacin and Ciprofloxacin between strains which were susceptible or resistant to Standard Anti-tubercular drugs.
Document emailed within 1 workday
Related Documents
Foroumadi, A.; Soltani, F. 2003: Antituberculosis agents. IX. in vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates Bollettino Chimico Farmaceutico 142(6): 248-250Foroumadi, A.; Soltani, F.; Moshafi, M.H. 2002: Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis Bollettino Chimico Farmaceutico 141(5): 394-396
Yu, M.C.; Suo, J.; Lin, T.P.; Luh, K.T. 1997: In vitro activity of ofloxacin against Mycobacterium tuberculosis Journal of the Formosan Medical Association 96(1): 13-16
Rosenfeld, M.; Spannuth, G.; Wempe, E.; Kunz, B.; Bartels, H.; Visser, K.; Seydel, J.K.; Ruschmeyer, H.J. 1986: In vitro activity of the new quinoline derivative ciprofloxacin alone and in combination against various Mycobacterium-, Salmonella- and Escherichia coli strains Arzneimittel-Forschung 36(6): 904-912
Cavuşoğlu, C.; Ciçek-Saydam, C.; Burhanoğlu, D.; Ozkalay, N.; Ozkaya, D.; Ozçam, H.; Bilgiç, A. 2002: Comparison of standard proportion dilution test and Etest for Mycobacterium tuberculosis sensitivity to ofloxacin and ciprofloxacin Mikrobiyoloji Bulteni 36(1): 118-123
Pracharktam, R.; Angkananukool, K.; Vibhagool, A. 2001: In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand Journal of the Medical Association of Thailand 84(9): 1241-1245
Tsukamura, M. 1990: Bactericidal activity of ofloxacin against Mycobacterium kansasii Kekkaku: 65(11): 719-721
Lee, A.S.G.; Tang, L.L.H.; Lim, I.H.K.; Wong, S.Yew. 2002: Characterization of pyrazinamide and ofloxacin resistance among drug resistant Mycobacterium tuberculosis isolates from Singapore International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 6(1): 48-51
Sayğan, M.B.; Ocak, F.; Cesur, S.; Tarhan, G.ül.; Ceyhan, I.; Gümüişlü, F.; Beker, G.ül.şa.; Güner, U.ğu.; Coşkun, E. 2007: Susceptibilities of Mycobacterium tuberculosis strains collected from regional tuberculosis laboratories to major antituberculous drugs Mikrobiyoloji Bulteni 41(3): 403-409
Dworniczak, S.; Niepsuj, G.; Konofalski, L.; Wojtyczka, R.D.; Idzik, D.; Kepa, M.; Wydmuch, Z.; Pacha, J.; Mazur, W.; Kieda-Szurkowska, J.; Nieroda-Müller, A.; Kozielski, J. 2005: Microbiological and molecular analysis of mycobacterium tuberculosis complex strains isolated from patients with pulmonary tuberculosis Pneumonologia i Alergologia Polska 73(1): 4-11
Vishnevskiĭ, B.I.; Narvskaia, O.V.; Mokrousov, I.V.; Istomin, E.A.; Otten, T.F. 2002: Sensitivity to levofloxacin of Mycobacterium tuberculosis strains with various phenotype isolated from patients with newly diagnosed and chronic tuberculosis Antibiotiki i Khimioterapiia 47(6): 31-33
Magana-Arachchi, D.N.; Perera, A.J.; Senaratne, V.; Chandrasekharan, N.V. 2010: Patterns of drug resistance and RFLP analysis of Mycobacterium tuberculosis strains isolated from recurrent tuberculosis patients in Sri Lanka Southeast Asian Journal of Tropical Medicine and Public Health 41(3): 583-589
Shaginian, I.A.; Nesterenko, L.N.; Grishina, T.D.; Safonova, S.G.; Golyshevskaia, V.I.; Gintsburg, A.L.; Khomenko, A.G.; Prozorovskiĭ, S.V. 1996: Genomic polymorphism in Mycobacterium tuberculosis strains Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 65-68
Kozińska, M.; Jakubowska, M.; Augustynowicz-Kopeć, E. 2013: Transmission of Mycobacterium tuberculosis pre-XDR strains belonging to the Beijing family Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 34(204): 316-319
Xing, L.-L.; Zhu, C.-M. 2008: The advance on the study of Mycobacterium tuberculosis Beijing/W family strains Zhonghua Liu Xing Bing Xue Za Zhi 29(9): 945-947
Shavkunov, A.S.; Lazarev, V.N.; Chernausova, L.N.; Kuz'min, A.V.; Govorun, V.M. 2002: Genetic heterogeneity of cytochrome CYP51 in clinical strains of Mycobacterium tuberculosis Voprosy Meditsinskoi Khimii 48(4): 361-367
Homorodean, D. 2005: A simple enzyme test for proving the resistance to isoniazid of Mycobacterium tuberculosis strains Pneumologia 54(2): 58-61
Vyazovaya, A.A.; Mokrousov, I.V.; Zhuravlev, V.Y.; Solovieva, N.S.; Otten, T.F.; Manicheva, O.A.; Vishnevsky, B.I.; Narvskaya, O.V. 2016: Molecular Characteristics of the Multidrug-Resistant Mycobacterium Tuberculosis Strains in the Northwest Russia Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 34(1): 30-33
Varela, G.; Carvajales, S.; Gadea, P.; Sirok, A.; Grotiuz, G.; Mota, M.I.; Ritacco, V.; Reniero, A.; Rivas, C.; Schelotto, F. 2005: Comparative molecular study of Mycobacterium tuberculosis strains, in times of antimicrobial drug resistance Revista Argentina de Microbiologia 37(1): 11-15
Osato, M.S. 1999: Effect of two balanced salt solutions on the bioavailability of ofloxacin and ciprofloxacin Advances in Therapy 16(5): 200-209